Products Search
CSR
Governance
governance that meets the approval of many different types of stakeholders
Board of Directors
BOD Composition (As of Dec. 2021)
| Category | Name | Responsibilities | Election date | Term expiry date |
|---|---|---|---|---|
| Executive Director | Jong-Soo Woo | Domestic business, Manufacturing, New Product Development Headquarters | 2016.03.18 | 2022.03.15 |
| Chong-Yoon Lim | Business Development | 2018.03.16 | 2024.03.26 | |
| Jong-Hoon Lim | Management Planning /CIO | 2017.03.10 | 2023.03.20 | |
| Non-executive Director | Dong-Ho Lee | Non-executive Director | 2016.03.18 | 2022.03.15 |
| Sung-Hoon Kim | Non-executive Director | 2016.03.18 | 2022.03.15 | |
| Dong-Cheol Suh | Non-executive Director | 2017.03.10 | 2023.03.20 |
2021 BOD Meetings
| Held On | Main resolution matters |
|---|---|
| Feb. 04, 2021 |
Report on the 2020 closing |
| Mar. 09, 2021 |
Convening the 11th Regular Shareholders’ General Meeting and setting the agenda Cash dividends CEO’s presentation on the operational status of the internal accounting management system Audit Committee’s report on evaluation of the operational status of the internal accounting management system |
| Mar. 23, 2021 |
Approval of the financial 2020 statements |
| Apr. 27, 2021 |
Report on 1Q settlement of accounts |
| Apr. 29, 2021 |
Report on 2Q settlement of accounts |
2020 BOD Meetings
| Held On | Main resolution matters |
|---|---|
| Feb. 07, 2020 |
Report on the 2019 closing |
| Mar. 04, 2020 |
Convening the 10th Regular Shareholders’ General Meeting and setting the agenda Cash dividends |
| Mar. 06, 2020 |
Adding the agenda for 11th Regular Shareholders’ General Meeting |
| Mar. 16. 2020 |
Approval of the financial 2019 statements |
| Mar. 20, 2020 |
Appointment of CEO |
| Apr. 28, 2020 |
Report on 1Q settlement of accounts Establishment of Hanmi pharm. code of Ethic |
| July. 29, 2020 |
Report on 2Q settlement of accounts |
| Oct. 30, 2020 |
Report on 3Q settlement of accounts |
| Dec. 15, 2020 |
Capitalization of reserve |